Lazard Asset Management’s AngioDynamics ANGO Stock Holding History

Lazard Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.01M	Sell	154,379 -199	-0.1%	-$2.27K	﹤0.01%	987
2026 Q1	$1.76M	Buy	154,578 +143,755	+1,328%	+$1.56M	﹤0.01%	956
2025 Q4	$139K	Buy	+10,823	New	+$134K	﹤0.01%	1706
2023 Q4	–	Sell	-5,727	Closed	-$41K	–	2244
2023 Q3	$41K	Buy	+5,727	New	+$47.7K	﹤0.01%	1907
2023 Q2	–	Sell	-5,351	Closed	-$55K	–	2287
2023 Q1	$55K	Buy	5,351 +416	+8%	+$5.33K	﹤0.01%	1760
2022 Q4	$67K	Hold	4,935	–	–	﹤0.01%	1677
2022 Q3	$100K	Sell	4,935 -1,647	-25%	-$36.2K	﹤0.01%	1477
2022 Q2	$127K	Buy	6,582 +1,518	+30%	+$31.1K	﹤0.01%	1421
2022 Q1	$109K	Sell	5,064 -3,933	-44%	-$89.2K	﹤0.01%	1373
2021 Q4	$247K	Buy	+8,997	New	+$248K	﹤0.01%	1234
2019 Q4	–	Sell	-1,556,054	Closed	-$28.7M	–	1523
2019 Q3	$28.7M	Buy	1,556,054 +44,252	+3%	+$865K	0.05%	271
2019 Q2	$29.8M	Sell	1,511,802 -88,046	-6%	-$1.79M	0.05%	270
2019 Q1	$36.6M	Buy	1,599,848 +1,114	+0.1%	+$24.2K	0.06%	214
2018 Q4	$32.2M	Buy	1,598,734 +79,683	+5%	+$1.65M	0.06%	212
2018 Q3	$33M	Buy	1,519,051 +912,318	+150%	+$20.3M	0.05%	230
2018 Q2	$13.5M	Buy	+606,733	New	+$12.4M	0.02%	367

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.7M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WCM

Weber Capital Management San Francisco, California $118M AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lazard Asset Management's ANGO Position: Q2 2026 in Review

Lazard Asset Management reduced its AngioDynamics (ANGO) stake by 0.13% in Q2 2026, selling an estimated $2.27K and leaving 154,379 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #987.

Lazard Asset Management first reported a position in ANGO in Q2 2018 and has held it in 16 quarters since. The position peaked at $36.6M in Q1 2019. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

Lazard Asset Management held 154,379 shares of AngioDynamics worth $2.01M as of Q2 2026.
Lazard Asset Management sold 199 AngioDynamics shares in Q2 2026, an estimated $2.27K.
AngioDynamics made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #987 holding.
Lazard Asset Management first reported a position in AngioDynamics in Q2 2018 and has held it in 16 quarters since.
Lazard Asset Management's AngioDynamics position peaked at $36.6M in Q1 2019.
162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.